Purchase Order 75A50120P00108
Award Date
9/24/20
Potential Completion Date
9/23/21
Potential Value
$5.4M
Awardee
Luminex Corp
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78727, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Luminex Corporation was awarded a $642,450 firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop an extended panel for the Luminex NXTAG COVID-19 diagnostic test. The contract is being performed in Austin, Texas over a period of four months ending July 1, 2020. This award was made under Special Instructions 019 of the department's Easy Broad Agency Announcement BAA-20-100-SOL-0002, which...
This is a $9,850,000.00 firm fixed price purchase order awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Luminex Corporation. The contract is to expand the use of Luminex's ARIES SARS-CoV-2 assay, which is a molecular diagnostic test for COVID-19. This award was not set aside for any specific business type. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions,...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $683,500 firm fixed price definitive contract to Luminex Corporation of Austin, Texas. The contract is for the delivery of Luminex's XMAP SARS-CoV-2 Multi-Antigen Antibody Typing Assay to support the agency's coronavirus COVID-19 response efforts. No set aside designation or major subcontractors were indicated. Luminex will provide its assay from September 2020 through July...
This is a $36,972.00 delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain division to Luminex Corp, a foreign-owned, for-profit manufacturer of biomedical diagnostic technologies based in Austin, Texas. The contract is for the delivery of NXTAG Respiratory Pathogen Panels (RPP) and has a completion date of February 5, 2025. The contract is a firm fixed-price award without any small business set-aside designations. Luminex holds several significant federal...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...
This is a $96,195.84 firm fixed price purchase order awarded by the Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Luminex Corp, a manufacturer of biological testing technologies, for the procurement of 24 units of the NxTAG Respiratory Pathogen Panel + SARS-CoV-2 test kits. The contract supports the Naval Health Research Center's (NHRC) laboratory testing requirements in San Diego, California. The award was made on a sole-source basis under the authority of 10 U.S.C....
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $241,355.50 firm fixed price purchase order to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of lab supplies, with no set-aside designation, and a completion date of October 1, 2021. Luminex is a provider of proprietary multiplex diagnostic solutions to federal agencies, including the CDC, Department of Veterans...
This is a $86,091.50 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a Defense agency, to Luminex Corp, a manufacturer of biological testing technologies. The contract is for the supply of multiplex diagnostic solutions, including the NxTAG Respiratory Pathogen Panel + SARS-CoV-2 assay kits, MAGPIX performance verification and calibration kits, and drive fluid, to be used in laboratories at the Naval Health Research Center in San Diego. This sole-source award was...
This is a $97,636.38 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corp, a manufacturer of biological testing technologies including multiplex diagnostic solutions. The contract is for the provision of lab supplies, and is not set aside. Luminex has previously provided the CDC, as well as other federal agencies like the Department of Veterans Affairs and Department of Defense, with immunology services, laboratory supplies,...
This is a firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Luminex Corporation, a manufacturer of biological testing technologies. The contract is for the delivery of RPP NXTAG (RUO) 96 TESTS, with a potential value of $129,790.00 and a completion date of May 30, 2018. This appears to be a direct award to Luminex, as there is no set-aside designation noted. Luminex has a...